Significance of Myocardial Tenascin-C Expression in Left Ventricular Remodelling and Long-Term Outcome in Patients with Dilated Cardiomyopathy
Tetsuro Yokokawa(Fukushima Medical University), Toshihisa Anzai(Hokkaido University), Satoshi Yasuda(Tohoku University), Hisao Ogawa(Kumamoto University Hospital), Takafumi Nakayama(National Cerebral and Cardiovascular Center), Toshiyuki Nagai(Hokkaido University), Taka‐aki Matsuyama(National Cerebral and Cardiovascular Center), Hatsue Ishibashi‐Ueda(United Cerebral Palsy), Yoshihiko Ikeda(National Cerebral and Cardiovascular Center), Takeshi Nakatani(National Cerebral and Cardiovascular Center), Yasuchika Takeishi(Fukushima Medical University), Keiko Ohta‐Ogo(National Cerebral and Cardiovascular Center), Yasuo Sugano(keiyu Hospital)
Cited by 53
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755